Profound Medical Q4 EPS Loss of $0.27, Revenue Misses by 21.9%
Profound Medical reported a Q4 loss of $0.27 per share, matching consensus estimates but widening from a $0.20 loss a year earlier. Q4 revenues were $5.98 million, 21.87% below estimates, while shares have fallen 5% year-to-date.
1. Q4 Financial Results
Profound Medical reported a loss of $0.27 per share for Q4 2025, in line with consensus estimates. Revenues came in at $5.98 million, missing the estimate by 21.87%.
2. Year-Over-Year and Quarterly Trends
The $0.27 loss widened from a $0.20 loss in Q4 2024. The company has beaten EPS estimates only once in the past four quarters and underperformed revenue estimates three times over the same period.
3. Outlook and Market Performance
Shares are down 5% year-to-date versus a 0.4% gain in the S&P 500. Consensus for Q1 2026 calls for a $0.27 loss on $6.9 million in revenue and a full-year loss of $1.02 on $34.45 million in revenue.